— Know what they know.
Not Investment Advice

ALKS NASDAQ

Alkermes plc
1W: +0.5% 1M: +10.4% 3M: -8.3% YTD: +56.8% 1Y: +48.7% 3Y: +64.0% 5Y: +42.9%
$44.32
-0.12 (-0.27%)
 
Weekly Expected Move ±4.8%
$39 $42 $44 $46 $48
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 73 · $7.4B mcap · 155M float · 1.33% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 62% of companies Debt: 17.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.75 (down 98%), Alkermes plc would be worth roughly what it owes.
Total debt $1.57B against a stock market value of $7.44B.
Distance to default 6.43 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $764.8M (short-term plus half of long-term), stock volatility 40.1%; Altman Z'' 1.67. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$2.5B +23.1% ▲
5Y CAGR: +5.4%
Total Liabilities
$711M +20.4% ▲
5Y CAGR: -4.2%
Shareholders Equity
$1.8B +24.2% ▲
5Y CAGR: +11.3%
Cash & Investments
$1.3B +75.5% ▲
5Y CAGR: +15.7%
Total Debt
$70M -7.3% ▼
5Y CAGR: -29.8%
Net Debt
-$1.0B -386.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$338M$292M$457M$291M$1.1B
Short-Term Investments$199M$316M$316M$461M$200M
Cash & ST Investments$536M$608M$773M$752M$1.3B
Net Receivables$327M$297M$333M$390M$334M
Inventory$150M$181M$186M$183M$197M
Other Current Assets$0$44M$192M$91M$79M
Total Current Assets$1.1B$1.1B$1.5B$1.4B$1.9B
Property, Plant & Equip.$457M$320M$318M$312M$299M
Goodwill & Intangibles$167M$121M$85M$84M$84M
Long-Term Investments$229M$132M$40M$73M$145K
Other Non-Current Assets$27M$146M$12M$17M$49M
Total Non-Current Assets$962M$834M$651M$640M$601M
Total Assets$2.0B$2.0B$2.1B$2.1B$2.5B
— Liabilities —
Accounts Payable$56M$33M$66M$46M$108M
Short-Term Debt$3M$3M$3M$0$7M
Deferred Revenue$6M$7M$3M$1M$0
Other Current Liabilities$77M$85M$360M$71M$429M
Total Current Liabilities$471M$498M$520M$465M$543M
Long-Term Debt$293M$290M$288M$0$0
Other Non-Current Liab.$32M$56M$50M$56M$61M
Total Non-Current Liabilities$441M$422M$413M$125M$168M
Total Liabilities$912M$920M$934M$591M$711M
— Equity —
Common Stock$2M$2M$2M$2M$2M
Retained Earnings-$1.5B-$1.7B-$1.3B-$976M-$735M
Accumulated OCI-$4M-$11M-$3M-$2M-$2M
Total Stockholders Equity$1.1B$1.0B$1.2B$1.5B$1.8B
Total Liabilities & Equity$2.0B$2.0B$2.1B$2.1B$2.5B
— Key Metrics —
Total Debt$416M$379M$372M$76M$70M
Net Debt$79M$87M-$85M-$216M-$1.0B
Total Investments$428M$448M$356M$534M$200M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms